1. Home
  2. MDV vs UNCY Comparison

MDV vs UNCY Comparison

Compare MDV & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$14.45

Market Cap

149.6M

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$5.86

Market Cap

126.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
UNCY
Founded
2015
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.6M
126.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
MDV
UNCY
Price
$14.45
$5.86
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$44.50
AVG Volume (30 Days)
35.1K
348.2K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
8.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,479,000.00
N/A
Revenue This Year
$0.13
N/A
Revenue Next Year
$0.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$3.71
52 Week High
$17.15
$11.00

Technical Indicators

Market Signals
Indicator
MDV
UNCY
Relative Strength Index (RSI) 44.84 51.58
Support Level $14.23 $5.35
Resistance Level $14.81 $6.95
Average True Range (ATR) 0.31 0.35
MACD -0.04 -0.09
Stochastic Oscillator 25.28 31.97

Price Performance

Historical Comparison
MDV
UNCY

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: